Article

Bioactive peptides from marine organisms: a short overview.

Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior, Ciudad Universitaria, Mexico 04510, DF, Mexico.
Protein and Peptide Letters (Impact Factor: 1.74). 04/2012; 19(7):700-7. DOI: 10.2174/092986612800793208
Source: PubMed

ABSTRACT Marine organisms are an immense source of new biologically active compounds. These compounds are unique because the aqueous environment requires a high demand of specific and potent bioactive molecules. Diverse peptides with a wide range of biological activities have been discovered, including antimicrobial, antitumoral, and antiviral activities and toxins amongst others. These proteins have been isolated from different phyla such as Porifera, Cnidaria, Nemertina, Crustacea, Mollusca, Echinodermata and Craniata. Purification techniques used to isolate these peptides include classical chromatographic methods such as gel filtration, ionic exchange and reverse-phase HPLC. Multiple in vivo and in vitro bioassays are coupled to the purification process to search for the biological activity of interest. The growing interest to study marine natural products results from the discovery of novel pharmacological tools including potent anticancer drugs now in clinical trials. This review presents examples of interesting peptides obtained from different marine organisms that have medical relevance. It also presents some of the common methods used to isolate and characterize them.

Full-text

Available from: Roberto Arreguin, Feb 27, 2014
2 Followers
 · 
334 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The vast oceans of the world, which comprise a huge variety of unique ecosystems, are emerging as a rich and relatively untapped source of novel bioactive compounds with invaluable biotechnological and pharmaceutical potential. Evidence accumulated over the last decade has revealed that the diversity of marine microorganisms is enormous with many thousands of bacterial species detected that were previously unknown. Associated with this diversity is the production of diverse repertoires of bioactive compounds ranging from peptides and enzymes to more complex secondary metabolites that have significant bioactivity and thus the potential to be exploited for innovative biotechnology. Here we review the discovery and functional potential of marine bioactive peptides such as lantibiotics, nanoantibiotics and peptidomimetics, which have received particular attention in recent years in light of their broad spectrum of bioactivity. The significance of marine peptides in cell-to-cell communication and how this may be exploited in the discovery of novel bioactivity is also explored. Finally, with the recent advances in bioinformatics and synthetic biology, it is becoming clear that the integration of these disciplines with genetic and biochemical characterization of the novel marine peptides, offers the most potential in the development of the next generation of societal solutions.
    Marine Drugs 05/2015; 13(5):2924-2954. DOI:10.3390/md13052924 · 3.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The remarkable growth of bio-based industry has led to a rapid increase in the bioprospecting activities. The marine biomes are a rich reservoir of unique life systems making them an attractive target for bioprospecting for identification and development of potential drug molecules for human therapeutics. Many of the drug molecules such as ara-c, trabecetidin and eribulin have been discovered from marine organisms. It is noteworthy that indigenous communities have developed, preserved as well as evolved the marine traditional knowledge from one generation to next. Pharmaceutical companies utilize marine life based traditional knowledge developed by the communities at various stages of drug development, unfortunately, many a times without having a mechanism of access and benefit sharing in place. One such example is the marine bioprospecting Fiji contract that illustrates the role played by Fijian community and the lacuna in access and benefit sharing mechanisms. The present study is an attempt to explore the mechanism of fair and equitable sharing of the benefits arising from use of marine bioresources with the local communities as marine traditional knowledge holders in marine areas. It briefly describes the various international conventions and protocols that emphasize on the development of fair and equitable benefit sharing mechanisms. The study proposes marine bioprospecting contracts that are based on mutually agreed terms among the key stakeholders (the State with the genetic resources, traditional knowledge holders and marine bioprospectors). Marine bioprospecting contracts eventually will need to be customized as per the legislation of a country because of territorial nature of law. Also, the marine bioprospecting contracts will differ from other bioprospecting contracts due to various unique parameters associated with the activity such as economics of deep sea explorations (expensive processes of exploration and sample extraction), continuous supply of sample, the jurisdiction of marine areas and traditional knowledge associated. The present study elucidates the concept of marine bioprospecting contracts by considering India as a case study emphasizing sharing of benefits with traditional knowledge holders as well as ensuring sustainable use of marine genetic resources by the pharmaceutical sector.
    01/2015; 3:176-187. DOI:10.1016/j.gecco.2014.11.015
  • Source
    11/2014; 87(2). DOI:10.4081/jbr.2014.4813